Literature DB >> 24481293

Precompetitive activity to address the biological data needs of drug discovery.

Ben Sidders1, Christoph Brockel2, Alex Gutteridge1, Lee Harland3, Peter Gildsig Jansen4, Robert McEwen5, David Michalovich6, Henrik Seidel7, Bertram Weiss7, Bryn Williams-Jones3, Mathew Woodwark8.   

Abstract

Mesh：

Year:  2014        PMID： 24481293     DOI： 10.1038/nrd4230

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  3 in total

1.  Causal reasoning on biological networks: interpreting transcriptional changes.

Authors:  Leonid Chindelevitch; Daniel Ziemek; Ahmed Enayetallah; Ranjit Randhawa; Ben Sidders; Christoph Brockel; Enoch S Huang
Journal:  Bioinformatics       Date:  2012-02-21       Impact factor: 6.937

2.  Getting pharmaceutical R&D back on target.

Authors:  Mark E Bunnage
Journal:  Nat Chem Biol       Date:  2011-06       Impact factor: 15.040

3.  Transcriptome analysis of human tissues and cell lines reveals one dominant transcript per gene.

Authors:  Mar Gonzàlez-Porta; Adam Frankish; Johan Rung; Jennifer Harrow; Alvis Brazma
Journal:  Genome Biol       Date:  2013-07-01       Impact factor: 13.583
  3 in total
  3 in total

1.  Intellectual property policies in early-phase research in public-private partnerships.

Authors:  Hilde Stevens; Geertrui Van Overwalle; Bart Van Looy; Isabelle Huys
Journal:  Nat Biotechnol       Date:  2016-05-06       Impact factor: 54.908

2.  ToxReporter: viewing the genome through the eyes of a toxicologist.

Authors:  Mark Gosink
Journal:  Database (Oxford)       Date:  2016-11-25       Impact factor: 3.451

3.  The price of progress: Funding and financing Alzheimer's disease drug development.

Authors:  Jeffrey Cummings; Carl Reiber; Parvesh Kumar
Journal:  Alzheimers Dement (N Y)       Date:  2018-06-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.